Mondragon BJ, Uribe CJC

Language: Spanish
References: 10
Page: 59-63
PDF size: 165.71 Kb.

ABSTRACT

“Carcinoid” is the term used to refer to (well-moderately differentiated) neuroendocrine tumors mainly in the stomach, intestine, appendix and lungs. Carcinoid tumors have been considered rare disorders, these derived from the embryonic gut. Carcinoid syndrome is a rare condition in patients with carcinoid tumors, which develops as a result of the release of bioactive amines into the bloodstream. Despite modifications concerning the treatment of patients with carcinoid syndrome in recent years, the prevalence of carcinoid heart disease remains high.

REFERENCES

1. Cornelis JM, Eef GW, Höppener J. The spectrum of carcinoid tumours and carcinoid syndromes. Ann Clin Biochem 2003; 40: 612-27.

2. Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Neuroendocrine Tumors, 2015. 10th Edition, Vol 1, Chapter 33: 531-534.

3. Jimenez S, Romero J. Sindrome Carcinoide y tumores neuroendocrinos gastricos. RAPD online 2009; 32: 278-285.

4. Kulke M, Mayer R. Carcinoid Tumors. N Engl J Med 1999; 340: 858-868.

5. Mann D. et al. Braunwald’s Heart Disease. The dilated, restrictive and infiltrative cardiomyopathies. 2015. 10th Edition, Vol 2, Chapter 65: 1570-1571.

6. Mansecal N. et al. Echocardiographic follow-up of treated patients with carcinoid syndrome. Am J Cardiol 2010;105:1588–1591.

7. Maroun J. et al. Guidelines for the diagnosis and management of carcinoid tumours. Part 1: The gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group. Current oncology 2006; 13:1-10.

8. Muller JE, et al. Factors associated with progression of carcinoid heart disease. N Eng J Med 2003; 348:1005-1015.

9. Musich MM, Guia de practica clínica tumores neuroendocrinos - sindrome carcinoide. OSECAC 2010; 20:1-26.

10. Rendon ME. Sindrome carcinoide manejo perioperatorio. RMA, anestesiología en oncología 2011; 34:S72-S77.